4
Changes in Ownership
Pelthos Therapeutics Inc. Filed Acc 0001919246-26-000101
Director sold 786 shares at an average $26.16 ($20,561)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pauls Matthew Director | 2026-07-02 | Sale 10b5-1 | −692 | $26.00 | $17,989 | 14,458 | D: show line 1 in the form |
| Pauls Matthew Director | 2026-07-02 | Sale 10b5-1 | −94 | $27.36 | $2,572 | 14,364 | D: show line 2 in the form |
| Open-market sales · 786 sh · avg $26.16 · $20,561 | |||||||
Loading xslF345X06/wk-form4_1783458216.xml…